Day One Biopharmaceuticals Inc (NAS:DAWN) Stock News, Headlines & Updates
Day One Biopharmaceuticals Inc Stock News from GuruFocus
- 1
Jun 10, 2025
Day One Biopharmaceuticals (DAWN) Welcomes New R&D Leader | DAWN Stock News
GuruFocus News • 8:16am
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
Marketwired • 8:00am
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development | DAWN Stock News
GuruFocus News • 7:58am
May 07, 2025
Day One Biopharmaceuticals (DAWN) Target Price Adjusted to $26 | DAWN Stock News
GuruFocus News • 5:00pm
Needham Adjusts Price Target for DAWN to $27, Maintains Buy Rating | DAWN Stock News
GuruFocus News • 7:39am
Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Developments
GuruFocus News • 1:21am
Q1 2025 Day One Biopharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:08pm
May 06, 2025
Day One Reports First Quarter 2025 Financial Results and Corporate Progress
Marketwired • 4:00pm
Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings: EPS of -$0.35 Beats Estimates, Revenue of $30.5M Slightly Exceeds Expectations
GuruFocus News • 3:57pm
May 05, 2025
Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Report Preview: What to Expect
GuruFocus News • 8:00am
Apr 22, 2025
Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025
Marketwired • 8:00am
Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025 | DAWN Stock News
GuruFocus News • 7:53am
Apr 17, 2025
Day One Biopharmaceuticals (DAWN) Sees Price Target Cut by BofA Analyst | DAWN Stock News
GuruFocus News • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news